Researchers say hydroxychloroquine could still prevent COVID-19
Scientists from the University of Oxford say the drug is being ‘discarded prematurely’
7th August 2020
-
The future is diversity
Across the pharma industry and throughout healthcare, the totems of difference and parity provide genuine opportunities for tangible change. Improved outcomes, a greater understanding of the human condition and an environment which includes everyone are all within our reach.
-
Care in the home
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are increasingly being empowered to manage their conditions at home
-
Radically digital
How COVID-19 will change the future of healthcare
News
View all
EU approves new indication for Novartis’ Xolair
Allergy drug approved for severe chronic rhinosinusitis with nasal polyps
7th August 2020
Second COVID-19 peak in the UK can be avoided with testing and tracing, study finds
Study co-led by UCL and the London School of Hygiene & Tropical Medicine
7th August 2020
GSK’s anti-BCMA drug Blenrep wins US approval
First anti-BCMA therapy to be approved anywhere in the world
7th August 2020
AZ’s Fasenra study confirms robust efficacy in eosinophilic asthma
Drug reduced annual rate of asthma exacerbations by 49%
6th August 2020
Top trending
-
Researchers say hydroxychloroquine could still prevent COVID-19
-
UK increases COVID-19 vaccine manufacturing capacity
-
AstraZeneca forges licensing agreement with Redx Pharma
-
Roche’s tumour-agnostic therapy Rozlytrek approved in EU
-
EU approves new indication for Novartis’ Xolair
-
Sanofi, GSK in advanced discussions with EU for COVID-19 vaccine
Web Exclusives
View all
COVID-19 therapy and drug interactions
An overview of current treatments and their potential drug interactions
Remote working in the life sciences industry
How to ensure post-lockdown success
Virtual care here to stay
Ninety percent of patients surveyed globally reported that quality of care was as good or better than prior in-person care
Never the same again
Gary Hughes explains why we’re witnessing a complete transformation of the clinical trial process in the wake of COVID-19
Magazine
View more from the latest edition
Out in the cold
Is pharma missing a trick by sidestepping academics for medical and scientific liaison (MSL) roles?
Radically digital
How COVID-19 will change the future of healthcare
Cancer: a new patient-centric ecosystem
Kulveer Singh looks at what’s needed to support a new patient-centric cancer care ecosystem for successful treatment and management of the disease
Fair game
The continuing challenges of competition law for the pharma sector
Biomarkers and a battle of the bases
Why RNA is the future of diagnostics
The perfect storm
Defining the gaps in antibiotic pandemic preparedness
Pressing ahead
3D bioprinting pushes the bounds of human tissue engineering
Care in the home
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are increasingly being empowered to manage their conditions at home
Thought Leadership
View all
The concordance conundrum: creating space for open dialogue between patients and HCPs
Creating space for open dialogue between patients and healthcare professionals
Coronavirus and the pharma supply chain
Getting medicines to those who need them
The outlook for the Euro in a post-COVID economy
Europe has endured some difficult months, but there is growing confidence in the eurozone's ability to push back against the pandemic
The concordance conundrum: the value of improving patient experience
Understanding the complexities of behaviour change
Webinars
View allDesigning Pharma organisations for success
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
